Leading the way

The industry's best and brightest people are part of the Vertex team. Collectively, their decades of experience helped us launch four breakthrough medicines within seven years and will guide the way forward as we work toward bringing more transformative medicines to people living with serious diseases around the world. 

A hand holds a marker writing on a piece of glass

The industry's best and brightest people are part of the Vertex team. Collectively, their decades of experience helped us launch four breakthrough medicines within seven years and will guide the way forward as we work toward bringing more transformative medicines to people living with serious diseases around the world. 

Leadership 

Our diverse leadership team includes industry luminaries and disrupters all working toward discovering tomorrow’s transformative medicines. 

Reshma Kewalramani, M.D., FASN
Chief Executive Officer and President
David Altshuler, M.D., Ph.D.
Executive Vice President and Chief Scientific Officer
Stuart A. Arbuckle
Executive Vice President and Chief Operating Officer
E. Morrey Atkinson, Ph.D.
Executive Vice President and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations
Jonathan Biller
Executive Vice President and Chief Legal Officer
Carmen Bozic, M.D.
Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer
Amit K. Sachdev
Executive Vice President, Chief Patient and External Affairs Officer
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer
Charles Wagner
Executive Vice President and Chief Financial Officer

Board of Directors

Our Board has been a source of stability and experience that has helped guide our growth from a small research startup to a global S&P 500 company that continues to execute on its mission of investing in scientific innovation to create transformative medicines for people with serious diseases in specialty markets. 

Four of our 11 (36%) Board Directors are from racial and ethnic minority groups, and five of 11 (45%) are women — these diverse perspectives combined with decades of experience will be an important source of guidance. 

Jeffrey Leiden, M.D., Ph.D.
Executive Chairman
Reshma Kewalramani, M.D., FASN
Chief Executive Officer and President
Sangeeta N. Bhatia, M.D., Ph.D.
Director
Lloyd Carney
Director
Alan Garber, M.D., Ph.D.
Director
Michel Lagarde
Director
Diana McKenzie
Director
Bruce Sachs
Director
Jennifer Schneider, M.D., M.S.
Director
Nancy Thornberry
Director
Suketu (Suky) Upadhyay
Director
Director
Jeffrey Leiden
Board
icon
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
 
Scientific & Technology Committee
 
Director
Reshma Kewalramani
Board
person icon
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
 
Scientific & Technology Committee
 
Director
Sangeeta Bhatia
Board
person icon
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
person icon
Management Development & Compensation Committee
 
Scientific & Technology Committee
icon
Director
Lloyd Carney
Board
person icon
Audit & Finance Committee
person icon
Corporate Governance & Nominating Committee
icon
Management Development & Compensation Committee
 
Scientific & Technology Committee
 
Director
Alan Garber
Board
person icon
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
person icon
Management Development & Compensation Committee
 
Scientific & Technology Committee
person icon
Director
Michel Lagarde
Board
person icon
Audit & Finance Committee
person icon
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
 
Scientific & Technology Committee
 
Director
Diana McKenzie
Board
person icon
Audit & Finance Committee
person icon
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
person icon
Scientific & Technology Committee
 
Director
Bruce Sachs
Board
Lead Independent Director
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
person icon
Management Development & Compensation Committee
icon
Scientific & Technology Committee
 
Director
Jennifer Schneider
Board
person icon
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
person icon
Scientific & Technology Committee
 
Director
Nancy Thornberry
Board
person icon
Audit & Finance Committee
 
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
 
Scientific & Technology Committee
person icon
Director
Suketu (Suky) Upadhyay
Board
person icon
Audit & Finance Committee
icon
Corporate Governance & Nominating Committee
 
Management Development & Compensation Committee
person icon
Scientific & Technology Committee
 

Member

Chair

Lead Independent Director